May 07, 2025 07:35 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Seven Pakistani soldiers killed, five injured in bomb attack on military convoy in southwestern Balochistan | Modi, Albanese eye to advance India-Australia Comprehensive Strategic Partnership during telephone conversation | Hold dialogue with all political parties on caste census: Mallikarjun Kharge writes to PM Modi | PM Modi meets NSA Ajit Doval amid India's wait for retaliation against Pahalgam terror attack | Pakistan grilled at UNSC amid rising tension with India after Pahalgam terror attack | 'We'll do everything we can': US House Speaker backs India in fight against terrorism after Pahalgam attack | Centre asks several states to conduct security mock drills amid tensions with Pakistan, first since 1971 | PM Modi holds meeting with Defence Secy as India plans retaliation against Pahalgam attack | Terror hideout busted in Kashmir's Poonch amid India-Pak border tensions after Pahalgam attack | India snaps water flow to Pakistan from Baglihar dam on Chenab river in Pahalgam fallout
Covid-19 vaccines
Image Credit: Pixabay

Serum Institute, Bharat Biotech get DCGI approval for emergency use of Covid-19 vaccines

| @indiablooms | Jan 03, 2021, at 05:58 pm

New Delhi/IBNS: Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.

Drug Controller General of India VG Somani said both firms submitted data based on their trial runs and both have been granted permission for "restricted use".

"We'll never approve anything if there is slightest of safety concern. The vaccines are 100 per cent safe," Somani said at a media briefing.

Sharing the news, Prime Minister Narendra Modi tweeted: "It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion."

Reacting to the approval, Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, said the risks taken with stockpiling the vaccine, have finally paid off.

The vaccines received the approval after they were cleared by a government-appointed panel on Jan 1 and 2.

The Serum Institute of India (SII) has made the vaccine Covishield developed by Oxford University and pharma major AstraZeneca, while Bharat Biotech has partnered with the Indian Council of Medical Research (ICMR) for its indigenous Covaxin.
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu